Department of Medicine 5 – Haematology and Oncology

Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML. (2025) Unglaub JM, Schlenk RF, Middeke JM, Krause S, Kraus S, Einsele H, Kramer M, et al. Journal article Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience (2024) Innocenti I, Mosca A, Tomasso A, Galitzia A, Scarfò L, Morelli F, Galli E, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article Oligoclonal CD4+CXCR5+ T cells with a cytotoxic phenotype appear in tonsils and blood (2024) Liang C, Spörl S, Xiao Y, Habenicht KM, Haeusl SS, Sandner I, Winkler J, et al. Journal article Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years (2024) Berning P, Fekom M, Ngoya M, Goldstone AH, Dreger P, Montoto S, Finel H, et al. Journal article Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells (2024) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Aigner M, Völkl S, et al. Journal article Repeated CXCR4 Blockade by Plerixafor Attenuates Transplant Vasculopathy in Murine Aortic Allografts (2024) Theil F, Kuckhahn A, Hörning A, Völkl S, Knab K, Fritz N, Gräbner C, et al. Journal article Metabolic profiling of single cells by exploiting NADH and FAD fluorescence via flow cytometry (2024) Abir AH, Weckwerth L, Wilhelm A, Thomas J, Reichardt C, Munoz LE, Völkl S, et al. Journal article, Original article CD19-CAR T-cell therapy induces deep tissue depletion of B cells (2024) Tur C, Eckstein M, Velden J, Rauber S, Bergmann C, Auth J, Bucci L, et al. Journal article Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMT (2024) Nagler A, Labopin M, Tischer J, Raiola AM, Kunadt D, Vydra J, Blaise D, et al. Journal article